在先天性黑色细胞瘤上的黑色素瘤
Llucia Alos1, Antonio Carrasco2, Cristina Teixidó3
1Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain; University of Barcelona, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; EORTC (European Organisation for Research and Treatment of Cancer) Melanoma Group.
Pathology, research and practice
|March 22, 2024
概括
在先天性黑色细胞瘤 (CMNi) 的黑色素瘤是罕见的,但有侵略性,特别是在大型/巨大的CMNi. 虽然小CMNi具有较低的黑色素瘤风险,但大CMNi可能导致具有明显分子特征的侵袭性瘤.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- kongenital melanocytic nevi (CMNi) 是一种常见的良性瘤,在出生时就存在.
- 在CMNi中产生的黑色素瘤是罕见的,但在儿科患者中可能不成比例地常见.
- 大型/巨型CMNi携带更高的发病风险,包括黑色素瘤的发展.
研究的目的:
- 审查先天性黑色细胞瘤中出现的黑色素瘤的独特临床和病理方面.
- 涵盖流行病学,病原性,临床表现和分子特征.
- 为了阐明这些特定黑色素瘤亚型的行为.
主要方法:
- 对CMNi中黑色素瘤的临床,病理和分子数据的文献综述.
- 对流行病学趋势和风险因素的分析.
- 对组织学和皮肤学特征的检查.
主要成果:
- 大/巨型CMNi中的黑色素瘤具有侵略性,可以在组织深处或皮肤外发生.
- 大多数CMNi具有NRAS突变,但CMNi上的黑色素瘤会获得额外的分子变异.
- 黑色素瘤风险对于小/中型CMNi来说很低,但对于大/巨型CMNi来说很大.
结论:
- 在CMNi上的黑色素瘤,特别是大型/巨大的黑色素瘤,具有独特的临床和分子特征.
- 了解这些特征对于诊断和管理这些侵袭性瘤至关重要.
- 进一步研究CMNi中黑色素瘤的分子驱动因素是有必要的.
相关概念视频
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Changes in Skin Color: Clinical Perspectives
2.0K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.0K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K


